Loading...

4,068 posters, 219 videos, 101 topics, 69 sessions, 14,365 authors, 6,128 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

Alzheimer's Association International Conference 2026

July 12-15, 2026 | London, United Kingdom, and Online

Alzheimer's Association International Conference 2026 banner

2121

A Preliminary Study Of Variation In Heavy Metal Concentrations Among Brain Donors With And Without Adrd Neuropathology

Part of Topic

Background: 

•Heavy metals are an omnipresent neurotoxicant, particularly in disadvantaged communities.
•Heavy metals are associated with Alzheimer’s disease and related dementias (ADRD).
•Timing and dosage of metal exposures and patterns of accumulation unclear.
•Existing studies focus on single metals or brain regions, or biofluids.
 
Objective:

Using an applied toxicology and exposomic approach we examine differential heavy metal accumulation in three brain regions in the context of donors’ lived experiences.

Methods:

We examined the brains of five brain donors (67% female, average age=79.4, average years banked=15, Table 1), using standardized digestion methods based on Krynitsky (1987), in the Trace Elements Clean Lab at Wisconsin State Laboratory of Hygiene. Tissue samples were placed into acid-cleaned and pre-weighed HotBlock digestion tubes and dissolved in concentrated acid. Sample digests were then analyzed by sector field inductively coupled plasma mass spectrometry based on EPA Method 200.8. Analysis of various isotopes were optimized per element to reduce and monitor isobaric interferences. A pre-selected 19 metal panel (Table 2) was examined across three brain regions (superior frontal gyrus (SFG), cerebellum (C), and putamen (P)) to determine high impact regions of interest and to test the feasibility of analysis for future investigations. For our exploratory analyses, we compared tissue concentrations: those with some ADRD pathology and those without.

Results:

We observed higher than expected metal concentration for lead (>0 µg/g, SFG = .14, P=.02, C=.21), mercury (>.005 µg/g, SFG = .21, P=.06, C=.02), cadmium (>.02 µg/g, SFG = .02, P=.03, C=.03), and copper (>5.1 µg/g, SFG = 4.3, P=5.2, C=6.3), especially in the cerebellum and putamen. The additional metals assessed were either below the limit of quantification or within the expected concentrations. In the exploratory analyses, we observed that those with some ADRD pathology had higher than expected metal concentration compared to non-ADRD pathology donors which were within the expected range.

Future Directions:

•Utilize nationally representative brain bank cohorts
•Incorporate life-course residential history
•Include measures of the occupational and military exposome

Conclusion:

•Quantifying metal concentrations in historically banked human brain tissues is feasible
•Metals accumulate differently by brain region
•Donors with ADRD neuropathology show differences in metal accumulation
•An exposomic framework allows for novel data extraction and integration
•Opportunity to examine life-course social and environmental exposures

Comments

Email is required but is not shown publicly.

Loading comments...

aaic2026 banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.